IRIS
MARCHESE, ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 41.228
AS - Asia 4.728
NA - Nord America 3.071
SA - Sud America 363
AF - Africa 90
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 49.488
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 40.409
US - Stati Uniti d'America 2.866
SG - Singapore 2.031
CN - Cina 1.125
VN - Vietnam 720
FR - Francia 408
BD - Bangladesh 393
BR - Brasile 219
HK - Hong Kong 155
FI - Finlandia 108
CA - Canada 79
DE - Germania 73
AR - Argentina 61
MX - Messico 49
JP - Giappone 47
GB - Regno Unito 41
IN - India 36
IQ - Iraq 36
CH - Svizzera 34
NL - Olanda 31
ID - Indonesia 30
ZA - Sudafrica 21
EC - Ecuador 20
CO - Colombia 19
JM - Giamaica 18
RU - Federazione Russa 18
TH - Thailandia 18
ES - Italia 16
CR - Costa Rica 14
MY - Malesia 14
PH - Filippine 14
IE - Irlanda 13
UZ - Uzbekistan 13
MA - Marocco 12
VE - Venezuela 12
TT - Trinidad e Tobago 11
DZ - Algeria 10
EG - Egitto 10
KR - Corea 10
PY - Paraguay 10
SA - Arabia Saudita 10
UA - Ucraina 10
PK - Pakistan 9
CL - Cile 8
KE - Kenya 8
PL - Polonia 8
HN - Honduras 7
JO - Giordania 7
PE - Perù 7
SE - Svezia 7
TR - Turchia 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
ET - Etiopia 6
KZ - Kazakistan 6
SK - Slovacchia (Repubblica Slovacca) 6
BG - Bulgaria 5
HU - Ungheria 5
NP - Nepal 5
OM - Oman 5
UY - Uruguay 5
BB - Barbados 4
BH - Bahrain 4
GT - Guatemala 4
NI - Nicaragua 4
PT - Portogallo 4
RO - Romania 4
TW - Taiwan 4
AO - Angola 3
AU - Australia 3
BE - Belgio 3
HR - Croazia 3
LT - Lituania 3
LY - Libia 3
MD - Moldavia 3
PR - Porto Rico 3
RE - Reunion 3
RS - Serbia 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AG - Antigua e Barbuda 2
AT - Austria 2
BO - Bolivia 2
CG - Congo 2
DO - Repubblica Dominicana 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
NO - Norvegia 2
PS - Palestinian Territory 2
SV - El Salvador 2
AL - Albania 1
BF - Burkina Faso 1
BM - Bermuda 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
Totale 49.464
Salva come PNG Salva come JPEG
Città #
Genova 23.538
Genoa 9.420
Rapallo 4.270
Vado Ligure 2.599
Singapore 982
San Jose 820
Lauterbourg 372
Ashburn 285
Ho Chi Minh City 228
New York 203
Hanoi 160
Hong Kong 147
Beijing 146
Helsinki 105
Santa Clara 102
Bordighera 96
Frankfurt am Main 57
Los Angeles 52
Rome 45
Milan 44
Council Bluffs 43
Tokyo 39
Zurich 34
Chicago 32
Dallas 32
Buffalo 31
Mexico City 30
Haiphong 29
Da Nang 27
Amsterdam 24
Naples 24
Orem 23
São Paulo 23
Tianjin 22
Houston 21
Florence 18
Atlanta 17
Biên Hòa 16
San Antonio 16
Bologna 15
Baghdad 14
Hải Dương 14
Brooklyn 13
Johannesburg 13
Boardman 12
Denver 12
Dublin 12
Guangzhou 12
Las Vegas 12
Montreal 12
Palermo 12
Philadelphia 12
Phoenix 12
San Francisco 12
San José 12
The Bronx 12
Washington 12
London 11
Turin 10
Bari 9
Des Moines 9
Dhaka 9
Kingston 9
Queens 9
Shenzhen 9
Toronto 9
Baltimore 8
Cardiff 8
Miami 8
Modena 8
Nuremberg 8
Princeton 8
Quảng Ngãi 8
Shanghai 8
Amman 7
Bangkok 7
Charlotte 7
City of London 7
Mumbai 7
Nairobi 7
Pensacola 7
San Diego 7
Tashkent 7
Can Tho 6
Catania 6
Curitiba 6
Guayaquil 6
Kansas City 6
Louisville 6
Nha Trang 6
Orlando 6
Poplar 6
Rio de Janeiro 6
Tampa 6
Thái Nguyên 6
Vĩnh Long 6
Warsaw 6
Addis Ababa 5
Asunción 5
Baku 5
Totale 44.707
Salva come PNG Salva come JPEG
Nome #
Confronto tra gli effeti dei mucolitici N-acetilcisteina, ambroxol, bromexina e sobrerolo sulla sintesi e sulla degradazione di biofilm di Staphylococcus aureus. 1.793
Potentially human pathogenic vibrios in marine and fresh bathing waters related to environmental conditions and disease outcome 273
Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients 235
Emergence of a KPC-3-Producing Escherichia coli ST69 as a Cause of Bloodstream Infections in Italy 234
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 230
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 230
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: should we get to the PK/PD root of the paradox? 224
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery 212
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 208
Analysis of clinical management of infected breast implants and of factors associated to successful breast pocket salvage in infections occurring after breast reconstruction 206
Epidemiological study of pathogens isolated from blood in Liguria during 2011. 200
. In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance 199
A Fatal Case of Nosocomial Legionnaires' Disease: Implications From an Extensive Environmental Investigation and Isolation of the Bacterium From Blood Culture. 197
DNA bacterial load in children with bacteremic pneumococcal community-acquired pneumonia. 196
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 191
Antimicrobial activity of eugenol and essential oils containing eugenol: A mechanistic viewpoint 190
Antibiotic susceptibility patterns and serotypes of antibiotic resistant and or invasive Streptococcus pneumoniae strains circulating in Italy 190
. Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe. 189
Phenotypic and genotypic characterization of Staphylococci causing breast peri-implant infections in oncologic patients. 188
Active surveillance of Streptococcus pneumoniae bacteremia in Italian children 187
Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis 186
Efficacy of N-acetyl-cysteine in combination with thiamphenicol in sequential (intramuscular/aerosol) therapy of upper respiratory tract infections even when sustained by bacterial biofilms 186
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 184
Antibacterial activity of polyphenols. 184
Bordetella holmesii endocarditis in a patient with systemic lupus erythematous treated with immunosuppressive agents. 182
Activity of Bay 12-8039 against well-characterised antibiotic resistant S.pyogenes. 181
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 181
Bloodstream infections in critically ill patients with COVID-19 180
Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp. 179
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 177
Antistaphylococcal activity of cefdinir, a new oral third-generation cephalosporin, alone and in combination with other antibiotics, at supra- and sub-MIC levels. 175
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study 174
Emergence of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains and spread of an isolate of sequence type 258 in the neuro-rehabilitation unit of an Italian hospital. 173
Phytochemicals for human disease: An update on plant-derived compounds antibacterial activity 171
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 168
In vitro antimicrobial activity of tigecycline against Gram-negative and Gram-positive pathogens collected in Northen Italy (T.E.S.T. program 2010). 167
Early carbapenem-resistant Klebsiella pneumoniae bacteraemia: should we expand the screening? 167
Breast implant infection due to Paenibacillus residui in a cancer patient 167
Adesione batterica e fungina a materiali protesici del cavo orale. 166
Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolated in Italy from patients with hospital-acquired infections. 166
Bacterial isolates from severe infections and their antibiotic susceptibility patterns in Italy: a nationwide study in the hospital setting 165
Clinical and Microbiological Characterization of Late Breast Implant Infections after Reconstructive Breast Cancer Surgery 165
Characterization of Fluoroquinolone-Resistant Escherichia coli Causing Septicemic Colibacillosis in Calves in Italy: Emergence of a Multiresistant O78 Clonal Group. 162
Epidemiology of multi-resistance Gram negative pathogen circulating in Liguria and molecular characterization of different carbapenemases. 162
Influence of in vitro simulated gastroduodenal digestion on the antibacterial activity, metabolic profiling and polyphenols content of green tea (Camellia sinensis). 162
Antibiotic susceptibility and serotype distribution in Streptococcus pneumoniae circulating in Italy: results of the SEMPRE surveillance study (2000-2002). 161
Plasmid loss from gram-negative bacteria exposed to subinhibitory concentrations of beta-lactam drugs and azithromycin. 159
Does the adoption of EUCAST susceptibility breackpoints affects the selection of antimicrobials to treat acute community-acquired respiratory tract infections? 159
Activity of Teicoplanin, Vancomycin and 8 Other Drugs Against Gram-Positive Pathogens Isolated in Italy 159
The Susceptibility of Candida albicans to Gamma-Radiations and Ketoco-nazole Depends on Transitional Filamentation. 159
Alteration of Membrane Permeability of Bacteria and Yeast by High Frequency Alternating Current (HFAC). 158
Antibiotic persistence: the role of spontaneous DNA repair response 158
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after cardiac surgery 154
Post antibiotic effect and delay of regrowth in strains carrying mutations that save proteins or RNA 154
In vitro activity of quinupristin/dalfopristin against selected bacterial pathogens isolated in Italy 153
The role of macrolides in Streptococcus pyogenes pharyngitis. 153
A new in vitro model system to study antimycotic drugs. 153
Predictive Models for Identification of Hospitalized Patients Harboring KPC-Producing Klebsiella pneumoniae. 152
Antistaphylococcal activity and metabolite profiling of manuka honey (Leptospermum scoparium L.) after in vitro simulated digestion 152
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 152
Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy. 150
Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment 150
Antibiotic resistance among S.pneumoniae isolated in Italy. 149
Pharmacokinetics of high-dose extended-infusion meropenem during pulmonary exacerbation in adult cystic fibrosis patients: a case series 148
Presynaptic release-regulating α2 receptors and Urolithins: A bridge between systemic EA administration and central health properties 147
Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults 147
Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy 146
Predictors of Mortality in Bloodstream Infections Caused by KPC-Producing Klebsiella pneumoniae: Importance of Combination Therapy. 146
Epidemiological study of pathogens isolated from blood in Liguria (January-April 2010). 145
Resistance patterns of lower respiratory tract pathogens in Europe. 144
Antibiotic susceptibility patterns and serotypes of nasopharyngeal Streptococcus pneumoniae circulating in healthy italian children. 144
Enhanced biofilm-production in pathogens isolated from patients with rare metabolic disorders 144
Interazione sinergica di teicoplanina e vancomicina con ceftazidime e azitromicina nei confronti di Pseudomonas aeruginosa. 144
AmpC-type plasmid mediated beta-lactamase in Klebsiella oxytoca e K.pneumoniae. 144
In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance 144
Detection of macrolide resistance genes in Streptococcus pneumoniae using a rapid method 142
F'lac integrative suppression in gyrB(Ts) mutan 142
Attività antibatterica di N-acetilcisteina sui principali patogeni responsabili di infezioni delle alte vie respiratorie e sui germi del cavo orale. 142
European survey of glycopeptide susceptibility: Staphylococcus spp. 142
Identification of a New Delhi metallo-β-lactamase-4 (NDM-4)-producing Escherichia coli in Italy. 141
First report of chronic pulmonary infection by KPC-3-producing and colistin-resistant Klebsiella pneumoniae sequence type 258 (ST258) in an adult patient with cystic fibrosis 141
Epidemiology and outcome of Klebsiellapneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-KP) infections in cardiac surgery patients: a brief narrative review 141
Activity of levofloxacin on contemporary respiratory pathogens 140
Antibiotic susceptibility tests directly on urine samples using Uro-Quick, a rapid automated system 140
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 140
In vitro activity of quinupristin/dalfopristin against selected bacterial pathogens isolated in Italy 139
The oxazolidinones as a new family of antimicrobial agent. 139
Activity of moxifloxacin (Bay 12-8039) against erythromycin-resistant Streptococcus pyogenes. 139
Antimicrobial activity of algae extracts against bacteria isolated from ear swabs. 139
Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa. 138
Isolation of Candida auris from invasive and noninvasive samples of a patient suffering from vascular disease, Italy, July 2019 138
Molecular characterization of hospital-acquired methicillin-resistant Staphylococcus aureus strains in pediatric outbreaks using variable tandem repeat analysis with spa and ClfB typing. 137
Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe. 136
Pleiotropic effect of sodium arsenite on Escherichia coli 136
In vitro interaction between ceftazidime and vancomycin/teicoplanin in the presence of azithromycin against Pseudomonas aeruginosa. 136
A pain in the back: anaerobic vertebral spondylitis of hematogenous origin 136
Genotypes and population genetics of cryptococcus neoformans and cryptococcus gattii species complexes in Europe and the mediterranean area 136
Antibiotic persistence: the role of spontaneous DNA repair. 135
European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. 135
Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations 135
Totale 18.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 153.798
article - articoli 99.673
book - libri 0
conference - conferenze 53.821
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 304
Totale 307.596
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.798 101 376 209 603 278 264 426 1.144 158 449 139 651
2022/20235.162 535 275 125 478 789 976 47 452 902 81 431 71
2023/20242.365 133 355 74 217 213 461 123 157 120 69 114 329
2024/20256.083 190 578 246 425 781 568 564 785 323 366 512 745
2025/202611.463 1.178 469 524 824 1.388 1.285 1.842 597 842 1.146 669 699
2026/2027944 944 0 0 0 0 0 0 0 0 0 0 0
Totale 49.730